Inogen (INGN) Asset Writedowns and Impairment (2013 - 2026)

Inogen (INGN) has 14 years of Asset Writedowns and Impairment data on file, last reported at $416000.0 in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment rose 150.6% year-over-year to $416000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 137.17% increase from a year earlier, with the FY2025 full-year figure at $822000.0, up 252.79% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $416000.0, up from $101000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for INGN reached as high as $1.4 million in Q3 2023 and fell as low as -$317000.0 in Q3 2024.
• Historically, Asset Writedowns and Impairment has averaged $387352.9 across 5 years, with a median of $363000.0 in 2022.
• Across the five-year window, Asset Writedowns and Impairment plunged 123.41% in 2024 and jumped 413.21% in 2025, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $363000.0 in 2022, then slipped by 4.13% to $348000.0 in 2023, then soared by 36.78% to $476000.0 in 2024, then tumbled by 78.78% to $101000.0 in 2025, then surged by 311.88% to $416000.0 in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $416000.0 in Q1 2026, $101000.0 in Q4 2025, and $274000.0 in Q3 2025.